|
|
???tair.name??? >
???browser.page.title.author???
|
"cho sf"???jsp.browse.items-by-author.description???
Showing items 1-11 of 11 (1 Page(s) Totally)
1
View [10|25|50] records per page
| 國家衛生研究院 |
2023-11-22 |
The prognosis performance of a neutrophil- and lymphocyte-associated gene mutation score in a head and neck cancer cohort
|
Yeh, TJ;Wang, HC;Cho, SF;Wu, CC;Hsieh, TY;Huang, CT;Wang, MH;Chuang, TM;Gau, YC;Du, JS;Liu, YC;Hsiao, HH;Pan, MR;Chen, LT;Moi, SH |
| 國家衛生研究院 |
2023-02-24 |
Deciphering the functions of telomerase reverse transcriptase in head and neck cancer
|
Yeh, TJ;Luo, CW;Du, JS;Huang, CT;Wang, MH;Chuang, TM;Gau, YC;Cho, SF;Liu, YC;Hsiao, HH;Chen, LT;Pan, MR;Wang, HC;Moi, SH |
| 國家衛生研究院 |
2021-03-30 |
Phase I study of ADI-PEG20 plus low-dose cytarabine for the treatment of acute myeloid leukemia
|
Tsai, HJ;Hsiao, HH;Hsu, YT;Liu, YC;Kao, HW;Liu, TC;Cho, SF;Feng, X;Johnston, A;Bomalaski, JS;Kuo, MC;Chen, TY |
| 國家衛生研究院 |
2019-12-18 |
An open-label, single-arm, two-stage, multicenter, phase II study to evaluate the efficacy of TLC388 and genomic analysis for poorly differentiated neuroendocrine carcinomas
|
Chen, MH;Chou, WC;Hsiao, CF;Jiang, SS;Tsai, HJ;Liu, YC;Hsu, C;Shan, YS;Hung, YP;Hsich, CH;Chiu, CH;Liu, TC;Cho, SF;Liu, TW;Chao, Y |
| 國家衛生研究院 |
2019-05 |
An open label, single-arm, two-stage, multicenter, phase II study to evaluate the efficacy and safety of TLC388 as second-line treatment in subjects with poorly differentiated neuroendocrine carcinomas (TCOGT1Z14)
|
Chen, MH;Chou, WC;Hsiao, CF;Liu, YC;Hsu, C;Yanshen, S;Hung, YP;Hsieh, CH;Chiu, CH;Liu, TC;Cho, SF;Liu, TW;Chao, Y |
| 國家衛生研究院 |
2017-06 |
A new scoring system for primary central nervous system lymphoma - a retrospective multi-center analysis in Taiwan
|
Su, YC;Lai, SW;Lin, CC;Lai, GM;Chiang, NJ;Wu, HC;Wu, YF;Chen, CC;You, JY;Cho, SF;Yang, Y;Yeh, CH;Hsueh, EJ;Chang, CL;Chen, CG;Chao, TY |
| 高雄醫學大學 |
2015 |
B細胞淋巴癌病人使用莫須瘤結合化療產生次發性惡性腫瘤之風險研究
|
卓士峰;吳宛璇;楊奕馨;張肇松; Cho, SF;Wu, WH;Yang, YH;Chang, CS |
| 高雄醫學大學 |
2015 |
B細胞淋巴癌病人使用莫須瘤結合化療產生次發性惡性腫瘤之風險研究
|
卓士峰;吳宛璇;楊奕馨;張肇松; Cho, SF;Wu, WH;Yang, YH;Chang, CS |
| 高雄醫學大學 |
2013 |
高LCN2表達可獨立為染色體正常之急性骨髓性白血病的好的預後因子
|
楊文祺;林柏每;楊敏瑜;劉益昌;張肇松;周文堅;許瑞峰;黃炯棠;卓士峰;余雯惠;林勝豐; Yang, WC;Lin, PM;Yang, MY;Liu, YC;Chang, CS;Chou, WC;Hsu, JF;Huang, CT;Cho, SF;Yu, WH;Lin, SF |
| 高雄醫學大學 |
2013 |
慢性骨髓性白血病慢性期之病人於imatinib治療失敗後行異體造血幹細胞移植之預後分析
|
劉益昌;蕭惠樺;張肇松;劉大智;楊文祺;許瑞峰;黃炯棠;卓士峰;吳承翰;蔡郁棻;林勝豐; Liu, YC;Hsiao, HH;Chang, CS;Liu, TC;Yang, WC;Hsu, JF;Huang, CT;Cho, SF;Wu, CH;Tsai, YF;Lin, SF |
| 國家衛生研究院 |
2011-09 |
Myeloid sarcoma mimicking nasopharyngeal carcinoma
|
Cho, SF;Liu, YC;Tsai, HJ;Lin, SF |
Showing items 1-11 of 11 (1 Page(s) Totally)
1
View [10|25|50] records per page
|
